Immunic, Inc. (IMUX)
NASDAQ: IMUX · Real-Time Price · USD
1.170
-0.120 (-9.30%)
At close: Apr 10, 2026, 4:00 PM EDT
1.160
-0.010 (-0.85%)
After-hours: Apr 10, 2026, 7:27 PM EDT
Immunic Market Cap
Immunic has a market cap or net worth of $152.64 million as of April 10, 2026. Its market cap has increased by 35.56% in one year.
Market Cap
152.64M
Enterprise Value
137.74M
1-Year Change
35.56%
Ranking
Category
Stock Price
$1.17
Market Cap Chart
Since April 15, 2019, Immunic's market cap has decreased from $243.61M to $152.64M, a decrease of -37.34%. That is a compound annual growth rate of -6.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 9, 2026 | 168.30M | 162.17% |
| Dec 31, 2025 | 64.20M | -28.73% |
| Dec 31, 2024 | 90.08M | 33.02% |
| Dec 29, 2023 | 67.72M | 9.04% |
| Dec 30, 2022 | 62.10M | -75.28% |
| Dec 31, 2021 | 251.21M | -20.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Apr 15, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Agenus | 170.87M |
| Precision BioSciences | 170.56M |
| Artiva Biotherapeutics | 168.07M |
| Unicycive Therapeutics | 167.83M |
| Whitehawk Therapeutics | 167.55M |
| Nkarta | 166.82M |
| Cartesian Therapeutics | 163.83M |
| Molecular Partners AG | 160.98M |